The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis

Lanqing Cong,Yan Deng,Shuo Cai,Gongzheng Wang,Xinya Zhao,Jingzhen He,Songbo Zhao,Li Wang
DOI: https://doi.org/10.1186/s13244-024-01629-4
IF: 5.0363
2024-02-29
Insights into Imaging
Abstract:To determine the value of periportal hyperintensity sign from gadobenate dimeglumine (Gd-BOPTA)-enhanced hepatobiliary phase (HBP) magnetic resonance imaging (MRI) for predicting clinical outcomes in patients with decompensated cirrhosis.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?